Akebia Return on Invested Capital from 2010 to 2024

AKBA Stock  USD 1.36  0.03  2.16%   
Check Akebia Ther financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Akebia main balance sheet or income statement drivers, such as Interest Expense of 9.4 M, Selling General Administrative of 3.1 M or Other Operating Expenses of 300.1 M, as well as many exotic indicators such as Price To Sales Ratio of 1.13, Dividend Yield of 0.0 or Days Sales Outstanding of 70.0. Akebia financial statements analysis is a perfect complement when working with Akebia Ther Valuation or Volatility modules.
  
This module can also supplement Akebia Ther's financial leverage analysis and stock options assessment as well as various Akebia Ther Technical models . Check out the analysis of Akebia Ther Correlation against competitors.
For information on how to trade Akebia Stock refer to our How to Trade Akebia Stock guide.

About Akebia Ther Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Akebia Ther income statement, its balance sheet, and the statement of cash flows. Akebia Ther investors use historical funamental indicators, such as Akebia Ther's Return on Invested Capital, to determine how well the company is positioned to perform in the future. Although Akebia Ther investors may use each financial statement separately, they are all related. The changes in Akebia Ther's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Akebia Ther's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Akebia Ther Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Akebia Ther. Please read more on our technical analysis and fundamental analysis pages.
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company was incorporated in 2007 and is headquartered in Cambridge, Massachusetts. Akebia Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 426 people.

Pair Trading with Akebia Ther

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Akebia Ther position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akebia Ther will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Akebia Ther could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Akebia Ther when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Akebia Ther - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Akebia Ther to buy it.
The correlation of Akebia Ther is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Akebia Ther moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Akebia Ther moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Akebia Ther can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Akebia Ther offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Akebia Ther's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Akebia Ther Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Akebia Ther Stock:
Check out the analysis of Akebia Ther Correlation against competitors.
For information on how to trade Akebia Stock refer to our How to Trade Akebia Stock guide.
Note that the Akebia Ther information on this page should be used as a complementary analysis to other Akebia Ther's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Complementary Tools for Akebia Stock analysis

When running Akebia Ther's price analysis, check to measure Akebia Ther's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Akebia Ther is operating at the current time. Most of Akebia Ther's value examination focuses on studying past and present price action to predict the probability of Akebia Ther's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Akebia Ther's price. Additionally, you may evaluate how the addition of Akebia Ther to your portfolios can decrease your overall portfolio volatility.
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Equity Valuation
Check real value of public entities based on technical and fundamental data
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Is Akebia Ther's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Akebia Ther. If investors know Akebia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Akebia Ther listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.28)
Revenue Per Share
1.038
Quarterly Revenue Growth
0.007
Return On Assets
(0.09)
Return On Equity
(5.53)
The market value of Akebia Ther is measured differently than its book value, which is the value of Akebia that is recorded on the company's balance sheet. Investors also form their own opinion of Akebia Ther's value that differs from its market value or its book value, called intrinsic value, which is Akebia Ther's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Akebia Ther's market value can be influenced by many factors that don't directly affect Akebia Ther's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Akebia Ther's value and its price as these two are different measures arrived at by different means. Investors typically determine if Akebia Ther is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Akebia Ther's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.